Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.1850 (-4.32%) ($13.1850 - $13.1850) on Tue. Nov. 15, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.3% (three month average) | RSI | 45 | Latest Price | $13.1850(-4.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 1.7% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLK(27%) URA(26%) VUG(26%) VT(25%) BND(23%) | Factors Impacting BCRX price | BCRX will decline at least -1.65% in a week (0% probabilities). SMH(-19%) VIXM(-12%) UUP(-3%) ARKG(-3%) VXX(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.65% (StdDev 3.3%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.98(1.58%) | 10 Day Moving Average | $12.57(4.89%) | 20 Day Moving Average | $13.01(1.35%) | To recent high | -11% | To recent low | 12.3% | Market Cap | $2.326b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |